Volume 135, Issue 2 , Pages 256-257, 26 June 2009
Enhanced external counterpulsation is an effective treatment for Syndrome X
Abstract
Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p
<
0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem.
Keywords: Syndrome X, External counterpulsation, Women
To access this article, please choose from the options below
PII: S0167-5273(08)00488-9
doi:10.1016/j.ijcard.2008.03.022
© 2008 Elsevier Ireland Ltd. All rights reserved.
Volume 135, Issue 2 , Pages 256-257, 26 June 2009
